Startup Logo

Phast Diagnostics

Phenotypic Antibiotic Susceptibility Test

  • 21-50 Team Size
  • 2017 Founding Year
  • Zürich Location
  • Company, Series A+ Project Status
  • Website
  • Biotechnology, international Markets

PhAST is a venture-backed AI healthcare startup developing computer vision technology for rapid pathogen identification and antibiotic resistance detection directly from patient samples. Our platform provides clinical decision support for doctors, workflow improvement for hospitals, and helps accelerate the drug development process for pharmaceutical companies. Founded in 2017 by an MIT PhD alumnus and an ETH Professor of Engineering, PhAST has built a strong founding team, built 6 prototypes of its diagnostic device, established research collaborations with world-class clinical collaborators at the Harvard Medical School, Brigham and Women’s hospital, and Seoul National University Hospital, and is advised by an international team of clinicians, scientists, and business experts across the USA and Switzerland. Company headquarters are located in the biotech innovation hub of Boston (USA) and the data analysis team is based in Zurich. This opening is for a position in the data analysis team in Zurich.